<DOC>
	<DOCNO>NCT01578941</DOCNO>
	<brief_summary>The study primarily investigate whether Treximet® ( Imitrex RT/naproxen sodium 500mg ) take first onset menstrual migraine terminate acute headache assist prevent headache recurrence need repeat abortive therapy ensue day menses .</brief_summary>
	<brief_title>An Investigation Safety Utility Treximet Treatment Menstrual Migraine</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Premenstrual Syndrome</mesh_term>
	<criteria>1 . Actively regularly cycling female age 19 year great . 2 . Normal ( subject ) menses within 6 week prior randomization 3 . History migraine ≤ 1 year duration International Classification Headache Disorders ( ICHD ) criteria 4 . History menstrual migraine ICHD criterion 1 . Not actively practice adequate contraception intend continue treatment . 2 . 15 day headache prior 3 month 3 . Prior use Treximet treatment menstrual migraine 4 . Uncontrolled hypertension 5 . Hemiplegic basilar migraine 6 . Clinical evidence coronary artery disease clinically significant relevant cardiac disease ( e.g . vasospastic angina ) 7 . History stroke transient ischemic attack 8 . History ischemic bowel disease 9 . Clinically significant hepatic disease 10 . History allergy NSAID triptan 11 . History gastritis , peptic ulcer disease , GI bleeding , gastric surgery</criteria>
	<gender>Female</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>menstrual migraine</keyword>
	<keyword>migraine</keyword>
	<keyword>treximet</keyword>
</DOC>